Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
Conditions: Ulcerative Colitis Interventions: Drug: Mebendazole Sponsors: Tanta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials

Alpha Lipoic Acid in Ulcerative Colitis
Conditions: Ulcerative Colitis Interventions: Drug: Mesalamine + alpha-lipoic acid; Drug: Mesalamine + Placebo Sponsors: Tanta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Nifuroxazide Sponsor:   Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Nifuroxazide Sponsor:   Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Nifuroxazide Sponsor:   Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Nifuroxazide Sponsor:   Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Nifuroxazide Sponsor:   Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Nifuroxazide Sponsor:   Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Nifuroxazide Sponsor:   Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2023 Category: Research Source Type: clinical trials